Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies.
AffiliationCancer Research UK - Group of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK. email@example.com
MetadataShow full item record
AbstractProstate cancers ability to invade and grow in bone marrow stroma is thought to be due in part to degradative enzymes. The formation of prostate skeletal metastases have been reproduced in vitro by growing co-cultures of prostatic epithelial cells in bone marrow stroma. Expression of urokinase plasminogen activator, matrix metalloproteinase 1 and 7 by prostatic epithelial cells were identified using immunocytochemistry. Also, in vivo tissue sections from human prostatic bone marrow metastases were stained. To establish the role of these enzymes on colony formation, inhibitory antibodies directed against urokinase plasminogen activator, matrix metalloproteinase 1 and matrix metalloproteinase 7 were added into primary prostatic epithelial cells and bone marrow stroma co-cultures. All prostatic epithelial cell cultures stained positively for matrix metalloproteinase 1, matrix metalloproteinase 7 and urokinase plasminogen activator. Generally prostatic epithelial cells derived from malignant tissues showed increased staining in comparison to epithelia derived from non-malignant tissue. In agreement with in vitro co-cultures, the in vivo tissue sections of prostate bone marrow metastases showed positive staining for all three enzymes. Inhibition studies demonstrated that blocking matrix metalloproteinase 1, matrix metalloproteinase 7 and urokinase plasminogen activator function reduced the median epithelial colony area significantly in bone marrow stroma co-cultures in vitro. Using a human ex-vivo model we have shown that matrix metalloproteinase 1, matrix metalloproteinase 7 and urokinase plasminogen activator play an important role in the establishment of prostatic epithelial cells within bone marrow.
CitationRole of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. 2002, 86 (7):1136-42 Br. J. Cancer
JournalBritish Journal of Cancer
- Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
- Authors: Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindan MV, Polychronakos C
- Issue date: 1993 Mar-Apr
- Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma.
- Authors: Lang SH, Clarke NW, George NJ, Allen TD, Testa NG
- Issue date: 1998 Feb 15
- Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
- Authors: Webber MM, Waghray A
- Issue date: 1995 Jul
- Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.
- Authors: Kirchheimer JC, Pflüger H, Ritschl P, Hienert G, Binder BR
- Issue date: 1985
- Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
- Authors: Festuccia C, Vincentini C, di Pasquale AB, Aceto G, Zazzeroni F, Miano L, Bologna M
- Issue date: 1995